JPMorgan Chase & Co. (NYSE:JPM) had its target price upped by investment analysts at Barclays from $304.00 to $330.00 in a ...

Some of the world's biggest polluters are reaping billions of dollars through a lax form of green finance, a new ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Trading 212's double hike this week comes as an easy access cash Isa battle has been reignited, with rival Plum having also ...

JPMorgan Chase stands head-and-shoulders above the rest of this group of largest U.S. banks by ROAA, while Morgan Stanley runs a pretty close second when its performance is measured by ROTCE. And with ...

The Bank of England's Prudential Regulation Authority, after consulting with the U.K. Treasury, said it will delay the implementation of what's called Basel 3.1 by one year, to Jan. 1, 2027. It had ...

KB Home (NYSE:KBH – Get Free Report) had its price target cut by equities researchers at JPMorgan Chase & Co. from $82.00 to ...

Apple is in talks with Barclays to replace Goldman Sachs as the tech giant’s credit card partner, says two sources familiar ...

Follow live coverage and analysis of earnings from Wells Fargo, JPMorgan Chase, Citigroup, Goldman Sachs, Bank of America, ...

It's been Goldman Sachs in the background since the Apple Card's launch in 2019. Ever since its introduction in 2019, the ...

JP Morgan analyst Kian Abouhossein shared views on Morgan Stanley‘s (NYSE:MS) fourth-quarter results reported today. The bank ...

Therapeutics (NASDAQ: ESPR) fell 5.8% after the company provided an update on its expected operating expenses for the fiscal year ending December 31, 2025. In a presentation at the 43rd Annual J.P.